Luigi Mangione’s lawyers renewed their effort Friday to end his New York murder and weapons prosecution, arguing that his August guilty plea to federal stalking charges prevents another trial over the killing of UnitedHealthcare CEO Brian Thompson, NBC News reported.

The dispute has indefinitely delayed a state trial that had been scheduled to begin Sept. 18. New York Supreme Court Justice Gregory Carro is expected to decide the dismissal motion Dec. 10.

The defense argues that the federal offenses and state charges overlap in their legal elements and address the same harm. In a letter to Carro, attorneys Karen Friedman Agnifilo, Marc Agnifilo and Jacob Kaplan emphasized that both prosecutions involved the same firearm at the same place and time.

Manhattan District Attorney Alvin Bragg’s office contends that the state murder case differs substantially from the federal prosecution, which focused on interstate stalking and cyberstalking resulting in death. Legal experts told NBC News that New York’s double jeopardy law requires the cases to address distinct harms for the state prosecution to proceed.

Prosecutors also pointed to U.S. District Judge Margaret Garnett’s earlier determination that the stalking offenses did not qualify as violent under the law. That ruling led to the dismissal of two federal counts that could have exposed Mangione to the death penalty.

Mangione admitted shooting Thompson with a 3D-printed firearm outside a midtown Manhattan hotel on Dec. 4, 2024. He faces a possible life sentence at his Dec. 18 federal sentencing. If the state case proceeds, its maximum sentence would be 25 years to life.